ABUS Forecast and Technical Stock Analysis
Buy candidate since 2019-09-20 PDF
Arbutus Biopharma Corporation gained 3.12% in the last trading day ( Friday, 20th Sep 2019 ), rising from $1.60 to $1.65 During the day the stock fluctuated 5.59% from a day low at $1.61 to a day high of $1.70. The price has risen in 6 of the last 10 days and is up by 5.77% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 106 095 more shares were traded than the day before. In total, 323 211 shares bought and sold for approximately $533 298.00.
- 30 day high of the ABUS stock price was $1.89 and low was $1.29.
- 90 day high was $2.49 and low was $1.29.
- 52 week high for Arbutus Biopharma Corporation - $10.00 and low - $1.29.
Arbutus Biopharma Corporation lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.72 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -34.01% during the next 3 months and, with 90% probability hold a price between $0.70 and $1.14 at the end of this period.
Only positive signals in the chart today. Arbutus Biopharma Corporation holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.64 and $1.54. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday September 18, 2019, which indicates further gains until a new top pivot has been found. Arbutus Biopharma Corporation has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 67 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Arbutus Biopharma Corporation finds support from accumulated volume at $1.63.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.09 between high and low, or 5.59%. For the last week, the stock has had a daily average volatility of 5.39%.
Our recommended stop-loss: $1.56 (-5.67%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 2 days ago.)
5.39 %Average volatility
Very Low Low Medium High Very High
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.
|ABUS $1.65 ($0.05 3.12%)|
ABUS is up $0.05 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ABUS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ABUS analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!